Size and Stratify the
Market with Precision
Smarter segmentation. Deeper market clarity.
Pharmaceutical teams must understand their therapy markets with precision—especially for rare or hard-to-diagnose conditions. MMIT leverages real-world data—from EMRs, lab results, and unstructured clinical notes—to uncover hidden patient segments and hyper-size target populations. These more complete insights enable smarter market segmentation and improved targeting accuracy.
Transform Rich Clinical Notes Into Integrated Insights
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.
Transform Rich Clinical Notes Into Integrated Insights
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
Transform Real-World Data Into Actionable Insights
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.